Skip to main content

Featured

5 Things to Know Today: Oil Tops $100, Tariffs Take Effect, TSX Slides — Sept 9

  September 9, 2026 Here's what's moving markets and your wallet today — from a fresh oil shock to a stock that just had its worst week in months. 1. Oil Tops $100 a Barrel for the First Time Since July Brent crude broke back above $100 a barrel overnight after Houthi drones and missiles struck Saudi Aramco energy facilities in Jazan, Abha and Najran, wounding more than 70 people and halting operations at several sites. The attacks followed U.S. strikes on Iranian oil tankers over the weekend, deepening a Middle East conflict now in its seventh month. What it means for you: Ottawa's fuel excise tax pause (extended to Jan. 31, 2027) is holding, but it can't offset a rising crude price — CAA's national average sits at 179.9¢/L today, up from 170.5¢/L just five weeks ago. If your tank is low, fill it before this keeps climbing. 2. TSX Slides for a Second Straight Day The S&P/TSX Composite closed Tuesday at 36,123.05, down 390.75 points (-1.07%), its second consecu...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment